BrainStorm Cell Therapeutics
BCLI
#9833
Rank
NZ$1.97 M
Marketcap
$0.37
Share price
3.51%
Change (1 day)
11.58%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$14.88 M

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are NZ$14.88 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$18.05 M24.49%
2021-12-31NZ$14.5 M-33.94%
2020-12-31NZ$21.96 M-21.02%
2019-12-31NZ$27.8 M200.39%
2018-12-31NZ$9.25 M18.6%
2017-12-31NZ$7.8 M525.73%
2016-12-31NZ$1.24 M-71.11%
2015-12-31NZ$4.31 M4.68%
2014-12-31NZ$4.12 M70.5%
2013-12-31NZ$2.41 M71.58%
2012-12-31NZ$1.41 M-12.38%
2011-12-31NZ$1.6 M-20.12%
2010-12-31NZ$2.01 M-41.9%
2009-12-31NZ$3.46 M-32.22%
2008-12-31NZ$5.11 M12.58%
2007-12-31NZ$4.54 M26.08%
2006-12-31NZ$3.6 M
2006-03-31NZ$14.49 M5778.79%
2005-03-31NZ$0.24 M239.78%
2004-03-31NZ$0.07 M59.86%
2003-03-31NZ$0.04 M74.06%
2002-03-31NZ$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$57.19 B 384,069.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.28 B 15,266.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.75 B 11,668.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.64 B 118,412.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.82 B 5,472.79%๐Ÿ‡บ๐Ÿ‡ธ USA